CurvaFix, Inc.
- 17/07/2023
- Series C
- $39,000,000
CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.
- Industry Medical Equipment Manufacturing
- Website https://curvafix.com/
- LinkedIn https://www.linkedin.com/company/curvafix-llc/
Related People
Steve DimmerFounder
30 years building medical technology companies. Deep experience leading development and commercialization of novel, disruptive health care solutions spanning diagnostic & therapeutic medical devices and drug delivery. Built world class teams in areas of orthopedics, pulmonology, oncology, diagnostics, and general surgery. Raised over $80 million from angels, VCs, family offices, and strategics. Inventor on over 100 U.S patents.